Enzyme Linked Immunosorbent Assay (ELISA)
Serum
Draw blood in a plain, red-top tube(s) or a serum gel tube(s).
1 mL
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 14 days | |
Frozen | 365 days | ||
Ambient | 14 days |
Negative <20 EU/mL
Borderline/Equivocal 20 – 25 EU/mL
Positive >25 EU/mL
Circulating immune complexes (CICs) are detectable in a variety of systemic disorders such as rheumatological, autoimmune, allergic diseases; viral, bacterial infections and malignancies. Although detection of CICs is neither essential nor specific for any disease, anti-C1q assay is likely to provide information regarding disease activity in lupus nephritis.
Once weekly
This test has been developed and performance parameters have been validated by IMMCO Diagnostics, Inc. This test has not been approved by the U.S. Food and Drug Administration (FDA); however, US FDA approval is not required for clinical use. It is not intended that clinical diagnosis and patient management decisions be made using these results alone.
This test has been validated using serum samples. The manufacturer has not determined the efficacy of this test when performed on CSF, plasma, joint or pleural fluid specimens. The performance characteristics of this test were determined by IMMCO Diagnostics Inc.
86332
Test Id | Test Order Name | Order LOINC Value |
---|---|---|
FCIC | Circulating Immune Complexes (CIC) | 27831-7 |
Result Id | Test Result Name |
Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
|
---|---|---|
Z0912 | Immune Complex | 27831-7 |